Risk stratification for sudden cardiac death after septal myectomy

Journal of Cardiology Cases

Volumn 3, Issue 2, 2011, Pages

  Rothman, Richard D ^a   Safiia, Muhamad A ^a   Lowry, Patricia A ^a   Mela, Theofanie ^a   Abbara, Suhny ^a   O'Callaghan, Caitlin ^a   Mark, Eugene J ^a   Vlahakes, Gus J ^a   Fifer, Michael A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cardioverter defibrillator; Heart disease; HOCM; Hypertrophic cardiomyopathy; Myectomy; Risk factors; Septal reduction therapy

Indexed keywords

ATENOLOL; DISOPYRAMIDE; GADOLINIUM; METOPROLOL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CHEST TIGHTNESS; DEFIBRILLATOR; DIZZINESS; DYSPNEA; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART PALPITATION; HEART SURGERY; HEART VENTRICLE TACHYCARDIA; HISTOPATHOLOGY; HOLTER MONITORING; HUMAN; HUMAN TISSUE; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; SEPTAL MYECTOMY; SUDDEN DEATH; SYNCOPE; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE;

EID: 79954600388     PISSN: 18785409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jccase.2010.12.002     Document Type: Article

References (12)

1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer 3rd WH, Spirito P, Ten Cate FJ, Wigle ED; Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687-713.
2. Fifer M.A., Vlahakes G.J. Management of symptoms in hypertrophic cardiomyopathy. Circulation 2008, 117:429-439.
3. Robbins R.C., Stinson E.B. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 1996, 111:586-594.
4. Ommen S.R., Maron B.J., Olivotto I., Maron M.S., Cecchi F., Betocchi S., Gersh B.J., Ackerman M.J., McCully R.B., Dearani J.A., Schaff H.V., Danielson G.K., Tajik A.J., Nishimura R.A. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005, 46:470-476.
5. ten Berg J.M., Suttorp M.J., Knaepen P.J., Ernst S.M., Vermeulen F.E., Jaarsma W. Hypertrophic obstructive cardiomyopathy Initial results and long-term follow-up after Morrow septal myectomy. Circulation 1994, 90:1781-1785.
6. Schulte H.D., Borisov K., Gams E., Gramsch-Zabel H., Losse B., Schwartzkopff B. Management of symptomatic hypertrophic obstructive cardiomyopathy-long-term results after surgical therapy. Thorac Cardiovasc Surg 1999, 47:213-218.
7. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., Mahon N.G., McKenna W.J. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000, 36:2212-2218.
8. Kwon D.H., Setser R.M., Popović Z.B., Thamilarasan M., Sola S., Schoenhagen P., Garcia M.J., Flamm S.D., Lever H.M., Desai M.Y. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study. Int J Cardiovasc Imaging 2008, 24:617-625.
9. O'Hanlon R., Grasso A., Roughton M., Moon J.C., Clark S., Wage R., Webb J., Kulkarni M., Dawson D., Sulaibeekh L., Chandrasekaran B., Bucciarelli-Ducci C., Pasquale F., Cowie M.R., McKenna W.J., et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010, 56:867-874.
10. Kwon D.H., Smedira N.G., Rodriguez E.R., Tan C., Setser R., Thamilarasan M., Lytle B.W., Lever H.M., Desai M.Y. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol 2009, 54:242-249.
11. Adabag A.S., Maron B.J., Appelbaum E., Harrigan C.J., Buros J.L., Gibson C.M., Lesser J.R., Hanna C.A., Udelson J.E., Manning W.J., Maron M.S. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008, 51:1369-1374.
12. Woo A., Williams W.G., Choi R., Wigle E.D., Rozenblyum E., Fedwick K., Siu S., Ralph-Edwards A., Rakowski H. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 2005, 111:2033-2041.